Currently predicting for Mon, 1 Apr 2024

Trading levels for CDTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.01 9.93 %
R2 0.97 5.84 %
R1 0.95 3.31 %
Current price: 0.92
Support S1 0.88 -4.87 %
S2 0.85 -7.40 %
S3 0.81 -11.49 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 0.92
Support S1 0.84 -8.47%
S2 0.763 -17.05%
S3 0.728 -20.87%

CDTX Predictions History

10 months ago
RKP predicted that CDTX for 2023-05-25 is going $1.40 (9.37%)

11 months ago
PredictionBot.Kathy predicted that CDTX for 2023-04-19 is going $1.07 (-4.53%)

11 months ago
PredictionBot.Warren predicted that CDTX for 2023-04-19 is going $1.09 (-2.50%)

11 months ago
johnfgavin predicted that CDTX for 2023-04-19 is going

Rank:

11 months ago
PredictionBot.Kathy predicted that CDTX for 2023-04-03 is going $1.18 (-3.02%)

11 months ago
PredictionBot.Warren predicted that CDTX for 2023-04-03 is going $1.22 (-0.35%)

11 months ago
goynesq.236280 predicted that CDTX for 2023-04-03 is going

11 months ago
RKP predicted that CDTX for 2023-03-31 is going $1.33 (4.72%)

1 year ago
PredictionBot.Kathy predicted that CDTX for 2023-03-28 is going $1.10 (-7.31%)

1 year ago
PredictionBot.Warren predicted that CDTX for 2023-03-28 is going $1.07 (-10.24%)

Click to get the best stock tips daily for free!

About Cidara Therapeutics

Cidara Therapeutics Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive... CDTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT